Status:

COMPLETED

Comparing Smoking Treatment Programs for Lighter Smokers - 1

Lead Sponsor:

University of Pennsylvania

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Tobacco Use Disorder

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

The purpose of this study was to compare two different types of Food and Drug Administration (FDA) approved smoking cessation medications (nicotine patch or bupropion) used in conjunction with two lev...

Detailed Description

The study compared a minimal level counseling model to a higher level counseling model plus one of two types of FDA approved smoking cessation products (bupropion or the nicotine patch)used to achieve...

Eligibility Criteria

Inclusion

  • Light smokers (6-15 cigarettes per day
  • Mentally and physically stable, non-pregnant, light smokers (6-15 cigarettes per day)

Exclusion

  • Please contact site for more information

Key Trial Info

Start Date :

September 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2009

Estimated Enrollment :

260 Patients enrolled

Trial Details

Trial ID

NCT00086411

Start Date

September 1 2003

End Date

June 1 2009

Last Update

August 6 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104 6178